Molecular epidemiology of Blastocystis in urban and periurban human populations in Arequipa, Peru

Kasandra Ascuña-Durand, Renzo S. Salazar-Sánchez, Ricardo Cartillo-Neyra, Jorge Ballón-Echegaray
doi: https://doi.org/10.1101/2020.06.17.20134064

Abstract

Blastocystis is one of the most common parasites found in the gut of humans and other hosts. It has a wide genetic diversity distributed around the world, predominating subtypes 1, 2 and 3 in South America countries. Nonspecific and inconsistent symptoms associated with this parasite made it controversial. The aim of this study was to estimate the prevalence of subtypes and determinate the epidemiological conditions associated with them. A total of 116 Blastocystis positive stool samples were processed by conventional PCR with Blastocystis-specific primers for subtypes 1 to 3. We identified subtype 1 (10.3%), subtype 2 (7.6%), subtype 3 (25.0%) and mixed infections (8.6%). We did not identify these Blastocystis subtypes in 48.7% of stool samples, assuming the presence of other subtypes in the zone. Any association was found between gastrointestinal symptoms and single subtype infections neither with mixed subtypes coinfections. However, our results suggest an association of Blastocystis subtype 2 and Irritable Bowel Syndrome (IBS, p=0.039). Besides, there was not an association between Blastocystis subtypes 1, 2 and 3 nor-mixed infections with epidemiological variables such as gender, age, presence of animals or vectors, places of food consumption, type of water consumption and water supply.

Introduction

Blastocystis is a protozoa found in the gut of humans and animals (1,2), but it remains unclear whether it is pathogenic (3). Some researchers report an association between Blastocystis and gastrointestinal symptoms and diseases (4,5) whereas other investigations fail to prove any correlation between both (6,7) or suggest Blastocystis could be consider as normal or beneficial for the microbiota (8,9).

Blastocystis is genetically diverse with 17 known subtypes (2) distributed throughout the world (10). Subtypes 1–9 are found in both humans and animals, subtype 9 is only found in humans (11) and subtypes 10–17 are found in domestics and wild animals (12). Subtypes 1, 2 and 3 are the most common subtypes associated to gastrointestinal symptoms (13,14) and the most prevalent in South America (15), while subtype 4 is mainly found Europe and Asia (14). Furthermore, Blastocystis transmission is generally associated with poor access to healthcare and unsanitary living conditions (11,16).

Although Blastocystis has been studied widely over the last decade, there have been few studies focused on this parasite in South America (17,18) with only one record from Peru related to Blastocystis subtypes (15). Blastocystis has been reported in some Peruvian cities (19–21) and Arequipa has the highest prevalence of 48.29 to 81.9% in elementary school children and low income localities (22,23). Our study aims to identify subtypes 1, 2 and 3 of Blastocystis in urban and periurban human populations in Arequipa city and to estimate their prevalence and their association with gastrointestinal symptoms and sanitary living conditions.

MATERIAL AND METHODS

Ethical statement

The protocol of this study was reviewed and approved by the Institutional Review Boards of the Universidad Peruana Cayetano Heredia, reference number 18006. Written informed consent for all participants was provide prior the study. Written assent and their parents’ informed consent was provided by minors under age of 18 years old prior the study participation.

Study site

Arequipa city is the second most populous in Peru, with approximately a million inhabitants, located in the country’s southern highlands at 2400 meters above sea level (24). The untidy growth of the city in last decades stablished two kinds of well-defined locations: periurban and urban localities, where periurban localities grew around the city with some limitation to access to basic services such as water, sanitation, health and education whereas urban areas have comprehensive access to these services. Thus, the socioeconomic status of participants from periurban areas is generally lower than urban participants (24,25).

Study population

Stools samples came from Blastocystis-positive adults and children, the recruitment method is described in a previous report (26). All participants completed epidemiological surveys to assess clinical and sanitary living conditions. We obtained stools from 119 Blastocystis-positive participants with and without gastrointestinal symptoms.

Detection of Blastocystis

All fresh samples were analyzed by rapid concentration with saline solution and direct observation method by standard microscopy and confirmed with blue methylene-stained stool smear under 1000X (26). Blastocystis positive samples were aliquot in cryovials and stored at −80°C.

DNA extraction and PCR amplification

The DNA was extracted from fresh stool using the Norgen Stool DNA Isolation Kit (Norgen, Biotek Corporation) and stored at −20°C. PCR was performed with the 2X PCR Taq Plus MasterMix (Applied Biological Materials Inc ABM) using Blastocystis-specific primers F:5′-GAAGGACTCTCTGACGATGA-3’/R:5′-GTCCAAATGAAAGGCAGC-3’ (351 bp) for subtype 1 (4), F:5′-CATGAGTAAAGTCCCGTWGGGA-3’/R:5′-CCCTTTTACAGTTCATTCGCCTA-3’ (1500 bp) for subtype 2 (27), and F:5′-TAGGATTTGGTGTTTGGAGA-3’/R:5′-TTAGAAGTGAAGGAGATGGAAG-3’ (526 bp) for subtype 3 (4) with the PCR setting parameters described in figure 1. Electrophoresis was performed by adding 8 µl of the PCR products to a 1.7% agarose gel and staining with GelRed® Nucleic Acid Gel Stain, 10,000X in Water (Biotium Inc.) for 30 min at 100 V.

Figure 1.
Figure 1.

PCR setting: Cycling parameters for subtype 1 and 3 are represented in bold dashed line, for subtype 2 is in bold solid line.

Statistical analysis

The association of Blastocystis subtypes with gastrointestinal symptoms and sanitary living conditions were analyzed with Chi-square and Fisher’s exact test. Blastocystis subtypes and patient’s age were analyzed by Kruskal-Wallis test. For the epidemiological analysis, we restricted the data to those participants from urban and periurban communities (8 samples from rural areas were excluded) and selected variables that could explain the possible source of Blastocystis subtypes. All analyses were conducted using R 3.6.2 (28).

Results

We identified 119 Blastocystis positive individuals by standard microscopy including 50 co-infected with other parasites and commensals organisms. We were able to obtain DNA from 116 stool samples. Descriptive analysis of demographic characteristics from the selected participants shows ranged in age from 2 to 82 years old, with similar gender proportions (50.4% Female and 49.6% Male).

The PCR analysis identified samples with simple and mixed subtype infections (43.1% for simple infection and 8.6% for mixed infection). Blastocystis subtype 3 was the most prevalent in the study sample, followed by subtypes 1 and 2. The most common mixed subtypes identified was subtypes 1 and 3 (Table 1). We could not identify the subtypes 1, 2 or 3 of Blastocystis in almost half of the samples (48.7%) (Table 1). A higher frequency of subtype 3 was observed in urban and periurban localities. Subtype 2 was less frequent in periurban localities and subtype 1 in urban localities, besides only subtype 1 was identified in participants from rural localities (figure 2).

View this table:
Table 1:

Frequency and prevalence of Blastocystis subtypes and type of infection identified in the tested samples.

Figure 2.
Figure 2.

Blastocystis subtype distribution per kind of location. STx correspond to unknown Blastocystis subtype.

The descriptive analysis also shows the Blastocystis subtypes composition per home (n = 78 homes), where the most common composition is between subtypes 1 and 3 with 10.3% (8/78 homes), another important result was that 20 homes present only one subtype (between subtypes 1, 2 or 3) been the most prevalent subtype 3 in 15.4% of homes (12/78). A high proportion of homes had an unknown subtype (42.3%, 33/78) (figure 3 A). Additionally, we observed the presence of the 3 subtypes (1, 2 and 3) in one home in only one participant (figure 3 B), and the presence of the 3 subtypes studied and unknown subtype(s) in one home but in 4 different participants (figure 3 C).

Figure 3.
Figure 3.

Distribution of Blastocystis subtypes per home. *STx: unknown subtype. A. Homes with a single, double and triple interaction between subtype 1, 2, 3 and unknown. B. Triple interaction between subtypes 1, 2 and 3. C. Quadruple interaction between subtypes 1, 2, 3 and unknown.

We also observed coinfection of Blastocystis subtypes with other intestinal parasites. Coinfection of Blastocystis subtype 3 and Entamoeba coli was the most frequent (57.1%), followed by Chilomastix mesnilli (28.6%), Iodamoeba bütchlii (21.4%), Entomoeba histolytica (14.3%) and Giardia lamblia (7.1%). Coinfections of Blastocystis subtype 1 and other parasites were found in the following frequencies: E. coli and C. mesnilli = 57.1%, G. lamblia = 28.8%, I. bütchlii, E. histolytica and Endolimax nana = 14.3% We did not find any coinfections associated with Blastocystis subtype 2.

Individuals who participated in the study lives in different districts in Arequipa city from urban and periurban areas (figure 4). Furthermore, the spatial subtype distribution shows the presence of Blastocystis subtype 3 in more districts than other subtypes, as the most prevalent subtype. In districts like Cerro Colorado, Cercado, M. Melgar and Characato it was the only one Blastocystis subtype identified. Blastocystis subtype 2 was present in J. Hunter and JLByR districts as the unique subtype. Blastocystis subtypes different than 1, 2 or 3 (unknown subtype) were present in all districts across the city. Other districts have a mix of subtypes and. Tiabaya district, located in southwestern area of the city, shows the presence of Blastocystis subtypes 1, 2 and 3, including unknown subtypes. The map also shows a concentration of unknown subtypes in district of Paucarpata, northeast of the city.

Figure 4:
Figure 4:

Spatial distribution of Blastocystis subtypes considering all the district in the metropolis with urban and periurban localities in Arequipa.

In order to exclude cross intestinal symptoms and disorders caused by other parasites, the statistical analysis of clinical manifestations was performed with Blastocystis positive participants and negative coinfection. Fisher exact test showed no association between single subtypes infections and the individual gastrointestinal symptoms. However, it showed a statistically significant association between Blastocystis subtype 2 and IBS (p 177 = 0.039). Figure 5 shows the frequency of gastrointestinal symptoms by single and mixed subtype.

Figure 5.
Figure 5. Symptomatology percentage according to Blastocystis subtypes 1, 2, 3 and mixed.

We included in the analysis the portion of the sample with a Blastocystis subtype identified, considering the mixed Blastocystis subtypes (n = 10) as an additional sub-group to compare. We applied a Kruskall-Wallis test to evaluate the strength in association between age of participants and subtypes in the Blastocystis infection, but we couldn’t find a statistical association (p.value = 0.993). We did not find a statistically significant association between single and mixed Blastocystis subtypes with variables from sanitary living conditions chosen for analysis (Table 2).

View this table:
Table 2: Relationship between Blastocystis subtypes and sanitary living conditions.

Discussion

This study is the first large-scale study at molecular level carried out in Peru to determinate the presence and distribution of Blastocystis subtypes and its relationship with clinical and epidemiological aspects in urban and periurban communities of Arequipa, Peru. We found Blastocystis subtypes 1, 2 and 3, where Blastocystis subtype 3 was the most prevalent followed by subtype 1 and 2. Similar distribution and prevalence have been reported in South America (10,15,29) and some places around the world (4,30,31). However, other studies from Brazil, and Lao Democratic Republic shows subtype 1 is the most prevalent (32,33), while in Europe the most prevalent subtypes are 3 and 4 (34,35).

The only previous molecular study of Blastocystis in Peru identified the presence of subtypes 3 and an unknown subtype (15) in 13 participants. In our study we used a much larger sample size and identified subtypes 1, 2, 3 and unknown subtypes. Mixed-double infections between Blastocystis subtype 1, 2 and 3 with different proportions and combinations have been reported in Brazil, Turkey and Iran (4,30,32). In our result we report 8.6% mixed-double subtypes infections corresponding to subtypes 1 and 3. We also report a mixed-triple subtypes infection in only one sample for Blastocystis subtypes 1, 2 and 3.

We also report a high number of samples with unknown subtypes that was not expected according to the previously report from Peru (15). However, we could infer that exist another subtypes present in Arequipa human population, being possible due to local migration, touristic activities (31), or even zoonotic transmission due to farming activities (10). The unknown subtypes in our study could match with other subtypes reported in surrounding countries (15) that also can be supported by migration to Arequipa city.

Respecting to migration, it has been widely studied as one of the main factor that explain the urbanization of Chagas disease, a parasitic and endemic disease from rural areas in Arequipa (36,37), where constant migration since 1970’s from rural to urban environments created a new environment with rural customs as raising domestic animals in periurban communities around the city (38). Additionally, the lack of healthy sanitary conditions could also establish proper conditions to facilitate infection and transmission of enteroparasites. These reasons also could explain the distribution of subtypes into the city suggesting that geographical features, sociocultural activities and customs combined with unappropriated sanitary conditions are not a barrier that limit this parasite and subtypes to rural or urban environments. In contrast with the reported in Turkey, where exist a well-defined distribution of subtypes 5, 6 and 7 in rural and subtypes 1, 2 and 3 in urban areas (39).

Since the pathogenicity of Blastocystis was suggest in 1986 (40), the controversy has not stopped due to many research indicate the association of this parasite to symptoms and diseases and others do not. In that way, some studies suggest that some subtypes such as 1 and 3 are responsible of some gastrointestinal symptoms like abdominal pain, diarrhea, vomiting, flatulence (4,5), which is not found in our study. We can highlight that in symptomatic individuals the presence of subtype 2 shows an association with IBS; whereas other study shows the same Blastocystis subtypes in IBS individuals (41,42). However, we could not support this association with the individual symptomatology showed by participants in our study due only four participants showed this condition syndrome. By the other hand, it was reported that Blastocystis subtype 3 could have a carcinogenic influence or facilitate the proliferation and growth of existing cancer cells (43,44).

According to demographic variables, the scientific literature reports statistical differences between men and women mainly for the economic activities (18). Contrary to these results, we have not found statistical association between Blastocystis subtypes and sex, in spite of many adult woman are dedicated to welfare home in the study sample and considering this activity as risk of infection due to food contamination (45,46), lack of sanitation (18) and raising animals in periurban communities from Arequipa (36). By the other hand, age is another important demographic factor of exposition and play a key role in intestinal infections as referred in other studies (13,39,47). In this study median age in single-subtype infections has values over 30 years old while mixed infection is more frequent under 20 and subtype 3 has a normal distribution across ages (Figure 4). Regardless of these distribution, the outcome do not show a statistical association with Blastocystis subtypes, as was obtained in Malaysia where subtype 2 was significantly associated to ages under or equal 15 years old (48).

Coinfection or polyparasitism has an impact on morbidity and nutrition, causing increase in susceptibility and intensity of infections and overreacting of immune response (49). We found a low percentage of coinfection with non-pathogenic and pathogenic enteroparasites as E. coli, Ch. Mesnilli, E. histolytica and G. lamblia. Other studies have reported coinfection between Blastocystis and Dientamoeba fragilis or G. duodenalis (29)(50). We explored coinfections in our study under the scope that some Blastocystis subtypes are pathogens (51) and considering that coinfection can produce an increase the intensity of infections. Nevertheless, our results on clinical manifestations and coinfection could support the hypothesis that Blastocystis is a beneficial microorganism and part of the healthy microbiome (52) and not a pathogen as lately research has begun to showed associating Blastocystis with a healthy microbiome (8,9), a rich diet in vegetables (53) and a better immune status (7).

Some studies found a positive correlation between Blastocystis and bacterial richness which suggests that Blastocystis is most common in people with healthy bacterial flora and negative correlated to Bacteroides that is observed more prevalent in unhealthy people being able to use Blastocystis as to determine the health of the individual rather than the bacterial composition (8,9,54).

The exploration of sanitary variables had the aim to identify the Blastocystis subtype provenance and to determinate possible transmission routes and sources. The overall available literature has limited references about these associations, only subtype 3 is associated to not boiled water drinking behavior (48). Other variables as food consumption and raising animals has no association to subtypes 1 and 3 (55).

We could not find any association between epidemiological variables and subtypes 1, 2 or 3 of Blastocystis; similar results was reported to drinking water, hand and food washing behavior (56). However in rural places, socioeconomic position, food and water combined to raising animals is the reason of specific subtypes distribution in rural communities (39). General prevalence studies on intestinal parasite infections has associated the presence of Blastocystis infection to untreated water consumption, final feces disposal and inadequate hands washing habits (21,45).

Almost half of the positive samples in our study had an indeterminate subtype, which is an important limitation. We assume that this outcome is related likely to primers sensitivity. Other important limitation was not to consider in the study the presence of subtypes reported in lower proportions for south America, expecting similar results as previous reported to Peru. We suggest a deeper review in large population with other molecular techniques like NGS to elucidate the indeterminate subtypes in this study. We also suggest to explore the likely association between subtype two and three with IBS in murine model to discard this pseudo association.

Despite these limitations, the data obtained herein are the first on prevalence of Blastocystis and distribution of subtypes in Arequipa and will contribute to a better understanding of the molecular epidemiological role and context of this parasite. Likewise, our findings state the basis for future research and explore new hypothesis about distribution and clinical manifestations of Blastocystis subtypes in our region.

Conclusions

We report the presence of Blastocystis subtypes 1, 2 and 3 were detected in Arequipa communities, as widely reported in South America and other countries around the world. Infection with we suggest an association between Blastocystis subtype 2 and was associated with IBS. The statistical analysis shows that No significant association was found between sanitary living conditions and specific Blastocystis subtypes.

Data Availability

The data can be requested by email to the fist author.

Financial Support

We gratefully acknowledge financial support from Universidad Nacional de San Agustín (UNSA) for the project “Morphological, Molecular and Clinical Diagnosis of Blastocystis as an emerging disease in humans and its association with the treatment and keeping of animals”. Proyectos de Investigación Aplicada Inicial – 2017 Contrato IAI 002-2018-UNSA.

Acknowledgments

We thanks to Zoonotic Diseases Research Laboratory from Universidad Peruana Cayetano Heredia (ZDRL-UPCH) for permission in the use of georeferenced data of Arequipa city to build the map of Blastocystis subtypes distribution, to Drs. Irmia Paz, Victor Vásquez, Elí Martinez and Mr. Cirilo Neyra (UNSA) for their helpful contribution to this project.

Bibliography

  1. 1.↵
    Udonsom R, Prasertbun R, Mahittikorn A, Mori H, Changbunjong T, Komalamisra C, et al. Blastocystis infection and subtype distribution in humans, cattle, goats, and pigs in central and western Thailand. Infect Genet Evol [Internet]. 2018;65(April):107–11. Available from: https://doi.org/10.1016/j.meegid.2018.07.007
    OpenUrl
  2. 2.↵
    Stensvold CR, Suresh GK, Tan KSW, Thompson RCA, Traub RJ, Viscogliosi E, et al. Terminology for Blastocystis subtypes - a consensus. Trends Parasitol. 2007;23(3):93–6.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Skotarczak B. Genetic diversity and pathogenicity of blastocystis. Ann Agric Environ Med. 2018;25(3):411–6.
    OpenUrl
  4. 4.↵
    Khademvatan S, Masjedizadeh R, Yousefi-Razin E, Mahbodfar H, Rahim F, Yousefi E, et al. PCR-based molecular characterization of Blastocystis hominis subtypes in southwest of Iran. J Infect Public Health [Internet]. 2017;5–9. Available from: http://dx.doi.org/10.1016/j.jiph.2017.03.009
  5. 5.↵
    Kaneda Y, Horiki N, Cheng XJ, Fujita Y, Maruyama M, Tachibana H. Ribodemes of Blastocystis Hominis isolated in Japan. Am J Trop Med Hyg. 2001;65(4):393–6.
    OpenUrlAbstract
  6. 6.↵
    Cifre S, Gozalbo M, Ortiz V, Soriano JM, Merino JF, Trelis M. Blastocystis subtypes and their association with Irritable Bowel Syndrome. Med Hypotheses [Internet]. 2018;116(April):4–9. Available from: https://doi.org/10.1016/j.mehy.2018.04.006
    OpenUrl
  7. 7.↵
    Di Cristanziano V, D’Alfonso R, Berrilli F, Sarfo FS, Santoro M, Fabeni L, et al. Lower prevalence of Blastocystis sp. infections in HIV positive compared to HIV negative adults in Ghana. PLoS One. 2019;14(9):e0221968.
    OpenUrl
  8. 8.↵
    Andersen LOB, Bonde I, Nielsen HBHB, Stensvold CR. A retrospective metagenomics approach to studying Blastocystis. FEMS Microbiol Ecol. 2015;91(7):1–9.
    OpenUrlCrossRef
  9. 9.↵
    Andersen LOB, Karim AB, Roager HM, Vigsnæs LK, Krogfelt KA. Associations between common intestinal parasites and bacteria in humans as revealed by qPCR. Eur J Clin Microbiol Infect Dis [Internet]. 2016; Available from: http://dx.doi.org/10.1007/s10096-016-2680-2
  10. 10.↵
    Barbosa CVV, Barreto MM, Andrade R de J, Fernando Sodre C, Masini d’Avila-Levy J, Mauro Peralta5, Ricardo Pereira Igreja6, Heloisa Werneck de Macedo H, et al. Intestinal parasite infections in a rural community of Rio de Janeiro (Brazil): Prevalence and genetic diversity of Blastocystis subtypes. PLoS One. 2018;3(3):1–12.
    OpenUrl
  11. 11.↵
    Yoshikawa H, Tokoro M, Nagamoto T, Arayama S, Asih PBS, Rozi IE, et al. Molecular survey of Blastocystis sp. from humans and associated animals in an Indonesian community with poor hygiene. Parasitol Int [Internet]. 2016;65(6):780–4. Available from: http://dx.doi.org/10.1016/j.parint.2016.03.010
    OpenUrl
  12. 12.↵
    Stensvold CR, Clark CG. Current status of Blastocystis: A personal view. Parasitol Int [Internet]. 2016;65(6):763–71. Available from: http://dx.doi.org/10.1016/j.parint.2016.05.015
    OpenUrl
  13. 13.↵
    Khademvatan S, Masjedizadeh R, Yousefi-razin E. PCR-based molecular characterization of Blastocystis hominis subtypes in southwest of Iran. J Infect Public Health [Internet]. 2018;11(1):43–7. Available from: https://doi.org/10.1016/j.jiph.2017.03.009
    OpenUrl
  14. 14.↵
    Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Sunday E, Onuoha U, Fagbenro-Beyioku AF, et al. Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop [Internet]. 2013;126(1):11–8. Available from: http://dx.doi.org/10.1016/j.actatropica.2012.12.011
    OpenUrl
  15. 15.↵
    Ramírez JD, Sánchez A, Hernández C, Flórez C, Consuelo M, Giraldo JC, et al. Geographic distribution of human Blastocystis subtypes in South America. Infect, Genet Evol [Internet]. 2016;41:32–5. Available from: http://dx.doi.org/10.1016/j.meegid.2016.03.017
    OpenUrl
  16. 16.↵
    del Coco VF, Molina NB, Basualdo JA, Córdoba MA. Blastocystis spp.: avances, controversias y desafíos futuros. Rev Argent Microbiol [Internet]. 2017;49(1):110–8. Available from: http://dx.doi.org/10.1016/j.ram.2016.08.004
    OpenUrl
  17. 17.↵
    Ramírez JD, Flórez C, Olivera M, Bernal MC, Giraldo JC. Blastocystis subtyping and its association with intestinal parasites in children from different geographical regions of Colombia. PLoS One. 2017;12(2):1–13.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Barbosa CV, Barreto MM, Andrade R de J, Fernando Sodre C, Masini d’Avila-Levy J, Mauro Peralta, Ricardo Pereira Igreja, Heloisa Werneck de Macedo H, et al. Intestinal parasite infections in a rural community of Rio de Janeiro (Brazil): Prevalence and genetic diversity of Blastocystis subtypes. PLoS One. 2018;1–12.
  19. 19.↵
    Ibáñez Herrera N, Jara C. C, Guerra M. A, Díaz Limay E. Prevalencia del enteroparasitismo en escolares de comunidades nativas del Alto Marañón, Amazonas, Perú. Rev peru med exp salud publica. 2004;21(3):126–33.
    OpenUrl
  20. 20.
    Sánchez L, Gallardo J, Jara C. Prevalencia de infección por Blastocystis y protozoarios intestinales en niños de “Alto Trujillo”, La Libertad, Perú. Sciéndo [Internet]. 2011;14(1–2):36–45. Available from: http://revistas.unitru.edu.pe/index.php/SCIENDO/article/view/542/pdf_12
    OpenUrl
  21. 21.↵
    Choi B, Kim B. Prevalence and Risk Factors of Intestinal Parasite Infection among Schoolchildren in the Peripheral Highland Regions of Huanuco, Peru. Osong public Heal Res Perspect [Internet]. 2017;8(5):302–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29164041%http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5678195
    OpenUrl
  22. 22.↵
    Quispe C, Chiara Y, Moreno O. Elevada prevalencia de Blastocystis spp. en niños de una escuela periurbana. An Fac med. 2016;77(4):393–6.
    OpenUrl
  23. 23.↵
    Casquina-Guere L, Martínez-Barrios E. Prevalencia y epidemiología del parasitismo intestinal en escolares de nivel primario de Pucchún, Camaná, Arequipa, Perú, 2006. Neotrop Helminthol. 2011;5(2):1–9.
    OpenUrl
  24. 24.↵
    Instituto Nacional de Estadística e Informática - INEI. Censos Nacionales 2017: XII de Población, VII de Vivienda y III de Comunidades Indígenas. [Internet]. Lima-Perú; 2018. Available from: https://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1551/
  25. 25.↵
    Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health: final report: executive summary [Internet]. World Health Organization. 2009. Available from: https://apps.who.int/iris/handle/10665/69832
  26. 26.↵
    Salazar-Sánchez RS, Ascuña-Durand K, Cartillo-Neyra R, Vásquez-Huerta V, Martínez-Barrios E, Ballón-Echegaray J. Socio-demographic determinants associated with Blastocystis infection in Arequipa, Peru. medRxiv [Internet]. 2020;2020.06.07.20124941. Available from: https://www.medrxiv.org/content/10.1101/2020.06.07.20124941v1
  27. 27.↵
    Yoshikawa H, Iwamasa A. Human Blastocystis subtyping with subtype-specific primers developed from unique sequences of the SSU rRNA gene. Parasitol Int [Internet]. 2016;65(6):785–91. Available from: http://dx.doi.org/10.1016/j.parint.2016.03.002
    OpenUrl
  28. 28.↵
    R Project. What is R? [Internet]. Available from: http://www.r-project.org/about.html
  29. 29.↵
    Villamizar X, Higuera A, Herrera G, Vasquez-A LR, Buitron L, Muñoz LM, et al. Molecular and descriptive epidemiology of intestinal protozoan parasites of children and their pets in Cauca, Colombia: A cross-sectional study. BMC Infect Dis. 2019;19(1):1–11.
    OpenUrl
  30. 30.↵
    Dogan N, Aydin M, Tuzemen NU, Dinleyici EC, Oguz I, Dogruman-Al F. Subtype distribution of Blastocystis spp. isolated from children in Eskisehir, Turkey. Parasitol Int [Internet]. 2017;66(1):948–51. Available from: http://dx.doi.org/10.1016/j.parint.2016.10.008
    OpenUrl
  31. 31.↵
    Rojas-Velázquez L, Morán P, Serrano-Vázquez A, Fernández LD, Pérez-Juárez H, Poot-Hernández AC, et al. Genetic Diversity and Distribution of Blastocystis Subtype 3 in Human Populations, with Special Reference to a Rural Population in Central Mexico. Biomed Res Int. 2018;2018:1–7.
  32. 32.↵
    Malheiros AF, Stensvold CR, Clark CG, Braga GB, Shaw JJ. Short report: Molecular characterization of Blastocystis obtained from members of the Indigenous Tapirapé ethnic group from the Brazilian Amazon Region, Brazil. Am J Trop Med Hyg. 2011;85(6):1050–3.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Sanpool O, Laymanivong S, Thanchomnang T, Rodpai R, Sadaow L, Phosuk I, et al. Subtype identification of human Blastocystis spp. isolated from Lao People’s Democratic Republic. Acta Trop [Internet]. 2017;168(16):37–40. Available from: http://dx.doi.org/10.1016/j.actatropica.2017.01.006
    OpenUrl
  34. 34.↵
    Stensvold CR, Christiansen DB, Olsen KEP, Nielsen HV. Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea. Am J Trop Med Hyg. 2011;84(6):883–5.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    Forsell J, Granlund M, Stensvold CR, Clark GC, Evengård B. Subtype analysis of Blastocystis isolates in Swedish patients. Eur J Clin Microbiol Infect Dis. 2012;31(7):1689–96.
    OpenUrlCrossRefPubMed
  36. 36.↵
    Levy MZ, Bowman NM, Kawai V, Waller LA, Geny J, Benzaquen EC, et al. Periurban Trypanosoma cruzi– infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis [Internet]. 2006 [cited 2017 Jan 22];12(9):1345–52. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294737/
    OpenUrl
  37. 37.↵
    Bowman NM, Kawai V, Levy MZ, Cornejo del Carpio JG, Cabrera L, Delgado F, et al. Chagas Disease Transmission in Periurban Communities of Arequipa, Peru. Clin Infect Dis [Internet]. 2008 Jul 15 [cited 2014 Mar 31];46(12):1822–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18462104
    OpenUrl
  38. 38.↵
    Bayer AM, Hunter GC, Gilman RH, Cornejo Del Carpio JG, Naquira C, Bern C, et al. Chagas disease, migration and community settlement patterns in Arequipa, Peru. PLoS Negl Trop Dis [Internet]. 2009 Jan [cited 2014 Mar 31];3(12):e567. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2790340&tool=pmcentrez&rendertype=abstract
    OpenUrl
  39. 39.↵
    Koltas IS, Eroglu F. Subtype analysis of Blastocystis isolates using SSU rRNA-DNA sequencing in rural and urban population in southern Turkey. Exp Parasitol [Internet]. 2016;170:247–51. Available from: http://dx.doi.org/10.1016/j.exppara.2016.10.006
    OpenUrl
  40. 40.↵
    Success L, City K, Sheehan DJ, Raucher BG, McKitrick JC. Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol. 1986;24(4):548–50.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Shirvani G, Fasihi-Harandi M, Raiesi O, Bazargan N, Zahedi MJ, Sharifi I, et al. Prevalence and Molecular Subtyping of Blastocystis from Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Chronic Urticaria in Iran. Acta Parasitol [Internet]. 2019;(0123456789). Available from: https://doi.org/10.2478/s11686-019-00131-y
  42. 42.↵
    Dogruman-Al F, Kustimur S, Yoshikawa H, Tuncer C, Simsek Z, Tanyuksel M, et al. Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz, Rio Janeiro. 2009;104(5):724–7.
    OpenUrl
  43. 43.↵
    Chan KH, Chandramathi S, Suresh K, Chua KH, Kuppusamy UR. Effects of symptomatic and asymptomatic isolates of Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res. 2012;110(6):2475–80.
    OpenUrlPubMed
  44. 44.↵
    Mohamed AM, Ahmed MA, Ahmed SA, Al-Semany SA, Alghamdi SS, Zaglool DA. Predominance and association risk of Blastocystis hominis subtype I in colorectal cancer: A case control study. Infect Agent Cancer. 2017;12(1):1–8.
    OpenUrl
  45. 45.↵
    Banhos EF, Rocha JAM da, Pimentel ML, Batista ETM, Silva LM. Prevalence and risk factors for intestinal parasite infections in schoolchildren, in the city of Santarém, Pará State, Brazil. ABCS Heal Sci. 2017;42(3):137–42.
    OpenUrl
  46. 46.↵
    Pérez-Cordón G, Rosales MJ, Valdez RA, Vargas-Vásquez F, Cordova O. Detección de parásitos intestinales en agua y alimentos de Trujillo, Perú. Rev Peru Med Exp Salud Publica. 2008;25(1):144–8.
    OpenUrl
  47. 47.↵
    Tito RY, Chaffron S, Caenepeel C, Lima-Mendez G, Wang J, Vieira-Silva S, et al. Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota. Gut. 2019;68(7):1180–9.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Noradilah SA, Moktar N, Anuar TS, Lee IL, Salleh FM, Manap SNAA, et al. Molecular epidemiology of blastocystosis in Malaysia: Does seasonal variation play an important role in determining the distribution and risk factors of Blastocystis subtype infections in the Aboriginal community? Parasites and Vectors. 2017;10(1):1–12.
  49. 49.↵
    Pullan R, Brooker S. The health impact of polyparasitism in humans?: are we under-estimating the burden of parasitic diseases? Parasitology. 2008;135(7):783–94.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    Dullaert-De Boer M, Schuurs TA, Vermeer M, Ruijs GJHM, Van der Zanden, Adri GM an Weel JF, Bruijnesteinjn van Coppenraet LES. Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis?: results from a case-control study. 2019;
  51. 51.↵
    Kumarasamy V, Kuppusamy UR, Jayalakshmi P. Exacerbation of colon carcinogenesis by Blastocystis sp. PLoS One. 2017;12(8):1–19.
    OpenUrlCrossRefPubMed
  52. 52.↵
    Stensvold CR, van der Giezen M. Associations between Gut Microbiota and Common Luminal Intestinal Parasites. Trends Parasitol [Internet]. 2018;34(5):369–77. Available from: https://doi.org/10.1016/j.pt.2018.02.004
    OpenUrl
  53. 53.↵
    Forsell J, Bengtsson-Palme J, Angelin M, Johansson A, Evengård B, Granlund M. The relation between Blastocystis and the intestinal microbiota in Swedish travellers. BMC Microbiol. 2017;17(1):1–9.
    OpenUrlCrossRef
  54. 54.↵
    Krogsgaard LR, Andersen LOB, Johannesen TB, Engsbro AL, Stensvold CR, Nielsen HV, et al. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome. Clin Transl Gastroenterol [Internet]. 2018;9(6). Available from: http://dx.doi.org/10.1038/s41424-018-0027-2
  55. 55.↵
    Li LH, Zhou XN, D.ZW, Wang XZ, Wang LB, Jiang JY, et al. Molecular epidemiology of human Blastocystis in a village in Yunnan province, China. Parasitol Int. 2007;56(4):281–6.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Paulos S, Köster PC, de Lucio A, Hernández-de-Mingo M, Cardona GA, Fernández-Crespo JC, et al. Occurrence and subtype distribution of Blastocystis sp. in humans, dogs and cats sharing household in northern Spain and assessment of zoonotic transmission risk. Zoonoses Public Health. 2018;65(8):993–1002.
    OpenUrl
Back to top
Posted June 20, 2020.
Download PDF
Data/Code
Email
Molecular epidemiology of Blastocystis in urban and periurban human populations in Arequipa, Peru
Kasandra Ascuña-Durand, Renzo S. Salazar-Sánchez, Ricardo Cartillo-Neyra, Jorge Ballón-Echegaray
medRxiv 2020.06.17.20134064; doi: https://doi.org/10.1101/2020.06.17.20134064
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area